Evaluation of a Program to Reduce Home Environment Risks for Children with Asthma Residing in Urban Areas.

Int J Environ Res Public Health

Department of Health Promotion and Education, University of Cincinnati, Cincinnati, OH 45221-0068, USA.

Published: December 2021

Pediatric asthma morbidity is often linked to challenges including poor housing quality, inability to access proper medical care, lack of medications, and poor adherence to medical regimens. Such factors also propagate known disparities, by race and income, in asthma-related outcomes. Multimodal home visits have an established evidence base in support of their use to improve such outcomes. The Collaboration to Lessen Environmental Asthma Risks (CLEAR) is a partnership between the Cincinnati Children's Hospital Medical Center and the local health department which carries out home visits to provide healthy homes education and write orders for remediation should code violations and environmental asthma triggers be identified. To assess the strengths and weaknesses of the program, we obtained qualitative feedback from health professionals and mothers of children recently hospitalized with asthma using key informant interviews. Health professionals viewed the program as a positive support system for families and highlighted the potential benefit of education on home asthma triggers and connecting families with services for home improvements. Mothers report working to correct asthma triggers in the home based on the education they received during the course of their child's recent illness. Some mothers indicated mistrust of the health department staff completing home visits, indicating a further need for research to identify the sources of this mistrust. Overall, the interviews provided insights into successful areas of the program and areas for program improvement.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750910PMC
http://dx.doi.org/10.3390/ijerph19010172DOI Listing

Publication Analysis

Top Keywords

asthma triggers
12
environmental asthma
8
health department
8
health professionals
8
areas program
8
asthma
7
evaluation program
4
program reduce
4
reduce environment
4
environment risks
4

Similar Publications

[Thunderstorm asthma: current status and perspectives].

Zhonghua Jie He He Hu Xi Za Zhi

January 2025

Department of Pulmonary and Critical Care Medicine, NHC Key Laboratory of Diagnosis & Treatment of COPD/Inner Mongolia Key Laboratory of Respiratory Diseases, Inner Mongolia People's Hospital, Hohhot010017, China.

Thunderstorm asthma refers to the acute exacerbation of asthma triggered by extreme weather events, which poses life-threatening risks due to severe asthma attacks and strained medical resources. Recent climate changes, including global warming, the greenhouse effect, and increased carbon emissions, have increased the levels of environmental allergens, contributing to a higher incidence of asthma and other allergic diseases. In addition, the increasing frequency of thunderstorms has exacerbated the impact of thunderstorm asthma.

View Article and Find Full Text PDF

Topical steroid withdrawal (TSW) is described as an adverse reaction to topical glucocorticoids (TGCs). A pathophysiological mechanism has not been identified. There are no diagnostic criteria.

View Article and Find Full Text PDF

Asthma affects approximately 300 million individuals worldwide and the onset predominantly arises in childhood. Children are exposed to multiple environmental irritants, such as viruses and allergens, that are common triggers for asthma onset, whilst their immune systems are developing in early life. Understanding the impact of allergen exposures on the developing immune system and resulting alterations in lung function in early life will help prevent the onset and progression of allergic asthma in children.

View Article and Find Full Text PDF

Nephrotic syndrome (NS) and atopic diseases are linked through shared immunological pathways, with allergic triggers often contributing to NS relapses, particularly in immunoglobulin E (IgE)-mediated pathways. Omalizumab, a humanized monoclonal antibody targeting free and cell-bound IgE, is commonly used in treating atopic diseases. We presented a pediatric case with a history of eczema, asthma, and recurrent atopic rhinitis, who first developed NS at age three, responding well to steroid therapy.

View Article and Find Full Text PDF

Patients with severe eosinophilic asthma (SEA) can benefit from biologic therapy but some subjects may present an immune-mediated side effect. These patients will not meet the treatment goals and might have an increased risk of exacerbations. Monitoring these patients by determining blood eosinophil (BE) levels could be one of the tools that may allow a follow-up to prevent a worsening of asthma or exacerbations.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!